Literature DB >> 7586617

Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features.

L D Dorn1, E S Burgess, B Dubbert, S E Simpson, T Friedman, M Kling, P W Gold, G P Chrousos.   

Abstract

OBJECTIVE: Prolonged elevations of glucocorticoids have been linked to the effective disturbances experienced by patients with Cushing's syndrome. Major depression has been most commonly reported in patients with endogenous Cushing's syndrome. The purpose of this study was to determine whether these patients experience melancholic or 'atypical' subtype depression and to determine relations between current psychological functioning and factors such as duration and severity of Cushing's syndrome. DESIGN AND PATIENTS: We examined 33 adult patients with documented Cushing's syndrome and 17 hospitalized, matched controls, using standardized structured interviews and tests.
RESULTS: During the active phase of Cushing's syndrome (prior to and/or on admission), 66.7% of all patients reported histories meeting criteria for a psychiatric diagnosis. Of those with a diagnosis during Cushing's syndrome, 50% reported major depression. Upon presentation to this institution, atypical depression was the most common diagnosis involving 51.5% (n =17) of all enrolled patients. Of the 17 with atypical depression, 8 reported a co-morbid psychiatric disorder. The duration of Cushing's syndrome was an important factor in predicting whether patients sought psychological intervention or met criteria for psychiatric diagnosis.
CONCLUSION: Patients with active endogenous Cushing's syndrome exhibit significant psychopathology expressed primarily by atypical depression. Longer duration of Cushing's syndrome may place them at increased risk of such psychopathology.

Entities:  

Mesh:

Year:  1995        PMID: 7586617     DOI: 10.1111/j.1365-2265.1995.tb02614.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  31 in total

1.  Is 11beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?

Authors:  George P Chrousos
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

Review 2.  Characterization of persistent and recurrent Cushing's disease.

Authors:  Nina K Sundaram; Alessia Carluccio; Eliza B Geer
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 3.  Cushing syndrome: establishing a timely diagnosis.

Authors:  Judith Lowitz; Margaret F Keil
Journal:  J Pediatr Nurs       Date:  2015-02-24       Impact factor: 2.145

Review 4.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

Review 5.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 6.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

7.  Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas.

Authors:  Beatriz Lecumberri; Javier Estrada; José García-Uría; Isabel Millán; Luis Felipe Pallardo; Luis Caballero; Tomás Lucas
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 8.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Psychosocial morbidity in Cushing disease: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Rama Malhotra
Journal:  Endocrine       Date:  2009-04-09       Impact factor: 3.633

10.  Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients.

Authors:  E M Guinan; C Lowy; N Stanhope; P D Lewis; M D Kopelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.